GLPG2222

· Galapagos NV

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GLPG2222, covering 2016-07-29 to 2018-11-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis [Phase 2]